Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Atara Biotherapeutics, Inc. | 26,916 | reported | 16 Aug 2024 | tx 30+1,398,964−95,919 |
| ACELYRIN, Inc. | 0 | reported | 21 May 2025 | tx 5+650,000−650,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2025 | OTHER | ACELYRIN, Inc. | 121,587 | — | |
| 21 May 2025 | OTHER | ACELYRIN, Inc. | 525,000 | — | deriv |
| 17 Mar 2025 | SALE | ACELYRIN, Inc. | 3,913 | 2.74 USD | |
| 23 Jan 2025 | GRANT_AWARD | ACELYRIN, Inc. | 125,000 | 0.00 USD | |
| 25 Nov 2024 | GRANT_AWARD | ACELYRIN, Inc. | 525,000 | 0.00 USD | deriv |
| 16 Aug 2024 | SALE | Atara Biotherapeutics, Inc. | 877 | 6.63 USD | |
| 16 Aug 2024 | SALE | Atara Biotherapeutics, Inc. | 89 | 6.63 USD | |
| 16 Aug 2024 | SALE | Atara Biotherapeutics, Inc. | 192 | 6.63 USD | |
| 16 May 2024 | SALE | Atara Biotherapeutics, Inc. | 32,401 | 0.62 USD | |
| 04 Mar 2024 | SALE | Atara Biotherapeutics, Inc. | 10,044 | 0.72 USD | |
| 08 Jan 2024 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 475,000 | 0.00 USD | |
| 16 Nov 2023 | SALE | Atara Biotherapeutics, Inc. | 8,307 | 0.39 USD | |
| 16 Aug 2023 | SALE | Atara Biotherapeutics, Inc. | 5,050 | 1.65 USD | |
| 16 Aug 2023 | SALE | Atara Biotherapeutics, Inc. | 3,622 | 1.65 USD | |
| 16 May 2023 | SALE | Atara Biotherapeutics, Inc. | 985 | 2.04 USD | |
| 16 May 2023 | SALE | Atara Biotherapeutics, Inc. | 7,404 | 2.04 USD | |
| 02 Mar 2023 | SALE | Atara Biotherapeutics, Inc. | 4,221 | 3.63 USD | |
| 01 Mar 2023 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 155,375 | 0.00 USD | |
| 01 Mar 2023 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 349,593 | 0.00 USD | deriv |
| 16 Nov 2022 | SALE | Atara Biotherapeutics, Inc. | 3,612 | 4.49 USD | |
| 16 Aug 2022 | SALE | Atara Biotherapeutics, Inc. | 1,196 | 5.03 USD | |
| 16 Aug 2022 | SALE | Atara Biotherapeutics, Inc. | 2,234 | 5.04 USD | |
| 17 May 2022 | SALE | Atara Biotherapeutics, Inc. | 2,317 | 5.32 USD | |
| 17 May 2022 | SALE | Atara Biotherapeutics, Inc. | 906 | 5.32 USD | |
| 01 Mar 2022 | GRANT_AWARD | Atara Biotherapeutics, Inc. | 51,814 | 0.00 USD |